Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market

Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size, Share, Growth Analysis, By Product(Reagents and consumables, instruments, and software), By Technology(Digital PCR (dPCR), and quantitative PCR (qPCR)), By Application(Research applications, clinical applications, and forensic applications), By End-user(Hospitals & diagnostic centers, research laboratories & academic institutes, clinical research organizations, and others), By Region - Industry Forecast 2024-2031

Report ID: SQMIG35J2038 | Region: Global | Published Date: July, 2024
Pages: 242 | Tables: 117 | Figures: 77

Digital PCR (dPCR) and Real-time PCR (qPCR) Market Competitive Landscape

Global digital PCR (dPCR) and real-time PCR (qPCR) market is highly competitive and somewhat fragmented. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D.

Digital PCR (dPCR) and Real-time PCR (qPCR) Market Top Player's Company Profiles  

  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories, Inc.
  • QIAGEN N.V.
  • F. Hoffmann-La Roche Ltd.
  • Agilent Technologies, Inc.
  • Fluidigm Corporation
  • Merck KGaA
  • Takara Bio Inc.
  • Illumina, Inc.
  • Promega Corporation
  • Abbott Laboratories
  • Danaher Corporation
  • Becton, Dickinson and Company
  • GE Healthcare Life Sciences
  • Eppendorf AG
  • Analytik Jena AG
  • Enzo Biochem, Inc.
  • Luminex Corporation
  • BioFire Diagnostics, Inc.
  • Oxford Nanopore Technologies Ltd.

Digital PCR (dPCR) and Real-time PCR (qPCR) Market

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Digital PCR (dPCR) and Real-time PCR (qPCR) Market size was valued at USD 5341.6 billion in 2019 and is poised to grow from USD 5806.48 billion in 2023 to USD 12018.88 billion by 2031, growing at a CAGR of 8.8% in the forecast period (2024-2031).

digital PCR (dPCR) and real-time PCR (qPCR) market is highly competitive and somewhat fragmented. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D. 'Thermo Fisher Scientific Inc.', 'Bio-Rad Laboratories, Inc.', 'QIAGEN N.V.', 'F. Hoffmann-La Roche Ltd.', 'Agilent Technologies, Inc.', 'Fluidigm Corporation', 'Merck KGaA', 'Takara Bio Inc.', 'Illumina, Inc.', 'Promega Corporation', 'Abbott Laboratories', 'Danaher Corporation', 'Becton, Dickinson and Company', 'GE Healthcare Life Sciences', 'Eppendorf AG', 'Analytik Jena AG', 'Enzo Biochem, Inc.', 'Luminex Corporation', 'BioFire Diagnostics, Inc.', 'Oxford Nanopore Technologies Ltd.'

Several factors are responsible for the growth of the digital PCR (dPCR) and real-time PCR (qPCR) market including growing prevalence of infectious diseases, increasing genetic disorders, and the successful execution of Human Genome project during the forecast period.

Increasing number of patients caused due to viral infections/diseases increased concerns in the healthcare sector. As a result, digital PCR techniques are on the trend for discovering the drug or biomarker for the viral diseases. Moreover, due to the improvement in digital PCR techniques, it helps to detect the rare cancer biomarkers. Thus, researchers can use digital droplet PCR (ddPCR) along with molecular biology techniques to find out the new cancer biomarkers.

North America is holding the largest market share with a revenue of more than 35.0% in 2021, and is still expected to retain the same during the forecast period, owing to the presence of supportive government regulations and various initiatives about the development of healthcare infrastructure, growing prevalence of infectious and genetic diseases in the region, and an availability of the key manufacturers in the region are all expected to drive the regional market over the forecast period. The United States and Canada are the prominent countries boosting the market growth.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Digital PCR Market
Buy Now GET FREE SAMPLE
PCR Molecular Diagnostics Market
Buy Now GET FREE SAMPLE
Polymerase Chain Reaction (PCR) Market
Buy Now GET FREE SAMPLE
Digital Signal Processors (DSPs) Market
Buy Now GET FREE SAMPLE
Automotive Digital Signal Processors (DSPs) Market
Buy Now GET FREE SAMPLE
Real-Time Clocks (RTCs) Market
Buy Now GET FREE SAMPLE
Real-Time Payments Market
Buy Now GET FREE SAMPLE
Medical Digital Imaging System Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market

Report ID: SQMIG35J2038

$5,300
BUY NOW GET FREE SAMPLE